Synergistic Interaction between the HDAC Inhibitor, MPT0E028, and Sorafenib in Liver Cancer Cells In Vitro and In Vivo

Type: Correction
Notice date: 7/1/2018 0:00
Journal: Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
Publisher: American Association for Cancer Research
Notice DOI: 10.1158/1078-0432.ccr-18-1455
Original paper DOI: 10.1158/1078-0432.ccr-12-3909

Reasons